Hybridon HYBN, for discussion of antisense drugs. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Hybridon HYBN, for discussion of antisense drugs.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mounir Abouzakhm who wrote (20)	1/21/1998 11:06:00 PM
From: Bosco	of 42

Dear Mounir - sorry to hear that. Well, the problem with tech, especially biotech, is high risk and high burn rate. I ve not spent much time looking at HYBN financials, but my guesses are that it needs pile of cash. So the board probably has no other alternative to raise enough cash. While I don't ve HYBN, I am holding a bunch of IMUL. At least the latter still sit on a pile of cash. Even that is not reason enough. Both cos have to scrap the original visions and start all over again with a IND. That means they are back to step 1. And the original seductive image is gone also. better luck next time for both of us. regards, Bosco

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next